Anson Funds Management LP
- SEC CIK
- 0001491072
- Latest filing
- Aug 13, 2026
ENSC holding history
Ensysce Biosciences, Inc. in every 13F filed by Anson Funds Management LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ENSC overviewAll 13F holders of ENSCFull Q2 2026 holdings
- Shares (Q4 2024)
- 0
- Sold out in Q4 2024
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 4
- Since Q1 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2024 | 0 | $0 | 0.0% | −983,518−100.0% | Sold out | Holders |
| Q3 2024 | 983,518 | $236.0K | <0.1% | +983,518 | New | Holders |
| Q3 2023 | 0 | $0 | 0.0% | −36,261−100.0% | Sold out | Holders |
| Q2 2023 | 36,261 | $65.3K | <0.1% | +36,261 | New | Holders |
| Q3 2022 | 0 | $0 | 0.0% | −150,664−100.0% | Sold out | Holders |
| Q2 2022 | 150,664 | $131.0K | <0.1% | −1,724,703−92.0% | Reduced | Holders |
| Q1 2022 | 1,875,367 | $2.14M | 0.3% | +1,875,367 | New | Holders |